510(k) K150617

cobas HSV 1 and 2 Test by Roche Molecular Systems, Inc. — Product Code OQO

K150617 is an FDA 510(k) premarket notification submitted by Roche Molecular Systems, Inc. for the device "cobas HSV 1 and 2 Test". The FDA issued a decision of Substantially Equivalent on June 1, 2015. The device falls under product code OQO (Herpes Simplex Virus Nucleic Acid Amplification Assay), a Class II device regulated under 21 CFR 866.3305. Roche Molecular Systems, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
June 1, 2015
Date Received
March 10, 2015
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Herpes Simplex Virus Nucleic Acid Amplification Assay
Device Class
Class II
Regulation Number
866.3305
Review Panel
MI
Submission Type

A polymerase chain reaction (pcr)-based qualitative in vitro diagnostic test for the detection and typing of herpes simplex virus (hsv) dna using vaginal swab specimens.